3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Mesothelioma
53
Advanced Solid Tumors
53
Solid Tumor
51
Advanced Solid Tumor
41
Mesothelioma, Malignant
38
Solid Tumors
35
Unspecified Adult Solid Tumor, Protocol Specific
27
Carcinoma, Non-Small-Cell Lung
25
Retinoblastoma
14
Melanoma
14
Esophageal Neoplasms
14
Solid Tumor, Adult
13
Sarcoma
12
Ovarian Neoplasms
12
Lung Neoplasms
11
Carcinoma, Renal Cell
11
Uterine Cervical Neoplasms
10
Small Cell Lung Carcinoma
10
Stomach Neoplasms
9
Breast Neoplasms
9
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Pancreatic Neoplasms
7
Neoplasm Metastasis
7
Advanced Solid Tumours
7
Neoplasms
6
Urinary Bladder Neoplasms
5
Thyroid Neoplasms
5
Solitary Fibrous Tumor, Pleural
5
Malignant Solid Tumor
5
Interventions
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Advanced Solid Tumor, Adult
×
Other solid neoplasm
×
Clear all
NCT04972110
2025-10-30
ATTACC
Repare Therapeutics
Phase 1/2
Terminated
156 enrolled
19 charts